1. Altmedsresearch
2. dunnie36
3. bluewatercloud
4. sevap476
1.dunnie36 01/25/2018
R.W. Baird reiterates Outperform rating; PT lowered to $253 from $332
2.bluewatercloud 02/12/2018
Intercept Announces Phase 3 REVERSE Trial Evaluating OCA for the Treatment of NASH Patients with Compensated Cirrhosis
3.Altmedsresearch 09/12/2017
investigating claims
4.Altmedsresearch 02/01/2018
FDA adds Boxed Warning to highlight correct dosing of Ocaliva for patients with a rare chronic liver disease
5.Altmedsresearch 02/14/2018
$ICPT Earnings today
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW